Clinical Trial Update: Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating immunobridging/maintenance therapy versus non-bridging therapy in CAR-T treatment for low-risk relapsed/refractory B-cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Ruijin Hospital | Conditions: B-NHL, CART Therapy | Phase 2 | Status: RECRUITING